Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial.

In conclusion, a G-B standardized extract demonstrated therapeutic effectiveness in patients with GAD, without exhibiting significant difference with Alprazolam, but showing fewer cases of daytime sleepiness. The trial was registered at http://clinicaltrials.gov by identifier: NCT03702803. PMID: 30834253 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30834253?dopt=Abstract

Source: Biomed Res - March 6, 2019 Category: Research Authors: Romero-Cerecero O, Islas-Garduño AL, Zamilpa A, Herrera-Arellano A, Jiménez-Ferrer E, Tortoriello J Tags: Biomed Res Int Source Type: research